| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
National Institute of Radiological Sciences, Chiba 263-8555, Japan [R. A., R. F., A. F., Y. H., K. T., M. A.]; Chiba University, Chiba 263, Japan [R. F.]; National Cancer Center Research Institute, Tokyo 104, Japan [Y. T.]; Sackler School of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel [Y. S.]; Los Alamos National Laboratory, Los Alamos, New Mexico 87545 [A. K., S. B., D. J. C.]; Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [G. C. L.]; and Kinki University, Wakayama 649-64, Japan [K. S.]
DNA-dependent protein kinase (DNA-PK) controls signal transduction following DNA damage. However, the molecular mechanism of the signal transduction has been elusive. A number of candidates for substrates of DNA-PK have been reported on the basis of the in vitro assay system. In particular, the Ser-15 amino acid residue in p53 was one of the first such in vitro substrates to be described, and it has drawn considerable attention due to its biological significance. Moreover, p53 Ser-15 is a site that has been shown to be phosphorylated in response to DNA damage. In addition, crucial evidence indicating that DNA-PK controls the transactivation of p53 following DNA damage was reported quite recently.
To clarify these important issues, we conducted the experiments with dna-pkcs null mutant cells, including gene knockout cells. As a result, we detected enhanced phosphorylation of p53 Ser-18, which corresponds to Ser-15 of human p53, and significant expression of p21 and mdm2 following ionizing radiation. Furthermore, we identified a missense point mutation in the p53 DNA-binding motif region in SCGR11 cells, which were established from severe combined immunodeficient (SCID) mice and used for previous study on the role of DNA-PK in p53 transactivation.
Our observation clearly indicates that DNA-PK catalytic subunit does not phosphorylate p53 Ser-18 in vivo or control the transactivation of p53 in response to DNA damage, and these results further emphasize the different pathways in which ataxia telangiectasia-mutated (ATM) and DNA-PK operate following radiation damage.
This article has been cited by other articles:
|
|
 |
|
  X. Wu, P. Geraldes, J. L. Platt, and M. Cascalho The Double-Edged Sword of Activation-Induced Cytidine Deaminase J. Immunol., January 15, 2005; 174(2): 934 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. M. Moll and O. Petrenko The MDM2-p53 Interaction Mol. Cancer Res., December 1, 2003; 1(14): 1001 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Perkins, A. Nair, D. O. Cowley, T. Van Dyke, Y. Chang, and D. A. Ramsden Sensing of intermediates in V(D)J recombination by ATM Genes & Dev., January 15, 2002; 16(2): 159 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Daniel, R. A. Katz, G. Merkel, J. C. Hittle, T. J. Yen, and A. M. Skalka Wortmannin Potentiates Integrase-Mediated Killing of Lymphocytes and Reduces the Efficiency of Stable Transduction by Retroviruses Mol. Cell. Biol., February 15, 2001; 21(4): 1164 - 1172. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. L. Van, K.-W. Yim, D.-Y. Jin, G. Dapolito, A. Kurimasa, and K.-T. Jeang Genetic Evidence of a Role for ATM in Functional Interaction between Human T-Cell Leukemia Virus Type 1 Tax and p53 J. Virol., January 1, 2001; 75(1): 396 - 407. [Abstract] [Full Text]
|
|
|
|
|
|
C. Jhappan, T. M. Yusufzai, S. Anderson, M. R. Anver, and G. Merlino The p53 Response to DNA Damage In Vivo Is Independent of DNA-Dependent Protein Kinase Mol. Cell. Biol., June 1, 2000; 20(11): 4075 - 4083. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-M. Darbon, M. Penary, N. Escalas, F. Casagrande, F. Goubin-Gramatica, C. Baudouin, and B. Ducommun Distinct Chk2 Activation Pathways Are Triggered by Genistein and DNA-damaging Agents in Human Melanoma Cells J. Biol. Chem., May 12, 2000; 275(20): 15363 - 15369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sanchez-Prieto, J. M. Rojas, Y. Taya, and J. S. Gutkind A Role for the p38 Mitogen-activated Protein Kinase Pathway in the Transcriptional Activation of p53 on Genotoxic Stress by Chemotherapeutic Agents Cancer Res., May 1, 2000; 60(9): 2464 - 2472. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Wang, M. Guo, H. Ouyang, X. Li, C. Cordon-Cardo, A. Kurimasa, D. J. Chen, Z. Fuks, C. C. Ling, and G. C. Li The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest PNAS, February 15, 2000; 97(4): 1584 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Khosravi, R. Maya, T. Gottlieb, M. Oren, Y. Shiloh, and D. Shkedy Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage PNAS, December 21, 1999; 96(26): 14973 - 14977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Duckett, S. M. Bronstein, Y. Taya, and P. Modrich hMutSalpha - and hMutLalpha -dependent phosphorylation of p53 in response to DNA methylator damage PNAS, October 26, 1999; 96(22): 12384 - 12388. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
